Relationship between GFR, intact PTH, oxidized PTH, non-oxidized PTH as well as FGF23 in patients with CKD
Fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) are regulators of renal phosphate excretion and vitamin D metabolism. In chronic kidney disease (CKD), circulating FGF23 and PTH concentrations progressively increase as renal function declines.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
22 September 2020
|
| In: |
The FASEB journal
Year: 2020, Volume: 34, Issue: 11, Pages: 15269-15281 |
| ISSN: | 1530-6860 |
| DOI: | 10.1096/fj.202000596R |
| Online Access: | Resolving-System, kostenfrei, Volltext: https://doi.org/10.1096/fj.202000596R Verlag, kostenfrei, Volltext: https://faseb.onlinelibrary.wiley.com/doi/10.1096/fj.202000596R |
| Author Notes: | $hShufei Zeng, Uwe Querfeld, Martina Feger, Dieter Haffner, Ahmed A. Hasan, Chang Chu, Torsten Slowinski, Thomas Bernd Dschietzig, Franz Schäfer, Yingquan Xiong, Bingbing Zhang, Steffen Rausch, Katarina Horvathova, Florian Lang, Bernhard Karl Krämer, Michael Föller, Berthold Hocher |
| Summary: | Fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) are regulators of renal phosphate excretion and vitamin D metabolism. In chronic kidney disease (CKD), circulating FGF23 and PTH concentrations progressively increase as renal function declines. |
|---|---|
| Item Description: | Gesehen am 13.12.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1530-6860 |
| DOI: | 10.1096/fj.202000596R |